Source:http://linkedlifedata.com/resource/pubmed/id/17964608
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
25-26
|
pubmed:dateCreated |
2007-11-30
|
pubmed:abstractText |
Tristetraprolin (TTP) is a tandem zinc finger protein that can bind to AU-rich elements (AREs) in the 3'-untranslated regions (3'-UTR) in mRNAs of transiently expressed genes, e.g. tumor necrosis factor-alpha (TNF-alpha) and granulocyte macrophage colony-stimulating factor (GM-CSF). TTP increases the turnover rate of the target mRNAs, thereby reducing, for example, the expression of TNF-alpha and GM-CSF. We examined the role of beta(2)-agonists, cAMP analogs, and forskolin (an activator of adenylate cyclase) on TTP mRNA and protein expression by quantitative real-time RT-PCR and Western blotting in J774 murine macrophages and THP-1 human macrophages. All of these agents increased TTP expression. A nonspecific inhibitor of phosphodiesterases (PDEs) 3-isobutyl-1-methylxanthine (IBMX) and type IV PDE-inhibitor rolipram further enhanced the increase in TTP expression levels, suggesting a cAMP-mediated effect. A possible mediator of these effects is transcription factor activator protein 2 (AP-2), whereas nuclear factor kappaB (NF-kappaB) seemed not to play any role. This mechanism may, at least in part, explain the anti-inflammatory effects which beta(2)-agonists have been reported to have in macrophages.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Albuterol,
http://linkedlifedata.com/resource/pubmed/chemical/Bucladesine,
http://linkedlifedata.com/resource/pubmed/chemical/Forskolin,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte-Macrophage...,
http://linkedlifedata.com/resource/pubmed/chemical/RNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tristetraprolin,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0024-3205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
81
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1651-8
|
pubmed:meshHeading |
pubmed-meshheading:17964608-Albuterol,
pubmed-meshheading:17964608-Animals,
pubmed-meshheading:17964608-Blotting, Northern,
pubmed-meshheading:17964608-Bucladesine,
pubmed-meshheading:17964608-Forskolin,
pubmed-meshheading:17964608-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:17964608-Humans,
pubmed-meshheading:17964608-Macrophages,
pubmed-meshheading:17964608-Mice,
pubmed-meshheading:17964608-RNA Stability,
pubmed-meshheading:17964608-RNA-Binding Proteins,
pubmed-meshheading:17964608-Tristetraprolin,
pubmed-meshheading:17964608-Tumor Necrosis Factor-alpha
|
pubmed:year |
2007
|
pubmed:articleTitle |
Salbutamol increases tristetraprolin expression in macrophages.
|
pubmed:affiliation |
The Immunopharmacology Research Group, Medical School, University of Tampere, and Research Unit, Tampere University Hospital, 33014, Tampere, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|